Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15148 | 729 | 55.7 | 84% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
271 | 3 | MITOCHONDRIA//MITOCHONDRIAL GENOME//MITOCHONDRIAL DNA PART A | 43930 |
381 | 2 | MITOCHONDRIA//MELAS//MITOCHONDRIAL DISEASE | 17103 |
15148 | 1 | MITOENGN//MITOCHONDRIA TARGETED ANTIOXIDANTS//OXYS RATS | 729 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MITOENGN | address | 1881233 | 9% | 65% | 69 |
2 | MITOCHONDRIA TARGETED ANTIOXIDANTS | authKW | 1363500 | 6% | 71% | 46 |
3 | OXYS RATS | authKW | 1140315 | 5% | 83% | 33 |
4 | SKQ1 | authKW | 1046096 | 4% | 78% | 32 |
5 | MITOQ | authKW | 806960 | 5% | 57% | 34 |
6 | MITO PORTER | authKW | 589010 | 2% | 94% | 15 |
7 | TRIPHENYLPHOSPHONIUM | authKW | 521944 | 2% | 69% | 18 |
8 | MITOCHONDRIAL DRUG DELIVERY | authKW | 471904 | 2% | 87% | 13 |
9 | MITOCHONDRIAL GENE THERAPY | authKW | 463958 | 2% | 92% | 12 |
10 | SKQ | authKW | 463958 | 2% | 92% | 12 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 1443 | 39% | 0% | 281 |
2 | Pharmacology & Pharmacy | 692 | 20% | 0% | 145 |
3 | Cell Biology | 402 | 14% | 0% | 100 |
4 | Medicine, Research & Experimental | 348 | 9% | 0% | 67 |
5 | Biophysics | 217 | 7% | 0% | 53 |
6 | Chemistry, Medicinal | 146 | 5% | 0% | 36 |
7 | Geriatrics & Gerontology | 69 | 2% | 0% | 14 |
8 | Endocrinology & Metabolism | 66 | 5% | 0% | 36 |
9 | Genetics & Heredity | 59 | 5% | 0% | 38 |
10 | Chemistry, Multidisciplinary | 50 | 9% | 0% | 62 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MITOENGN | 1881233 | 9% | 65% | 69 |
2 | BELOZERSKY PHYSICOCHEM BIOL | 223659 | 11% | 7% | 79 |
3 | CHEM AGEING | 157869 | 1% | 54% | 7 |
4 | MOL DESIGN PHARMACEUT | 146933 | 3% | 18% | 20 |
5 | MITOCHONDRIAL BIOL UNIT | 140851 | 4% | 12% | 29 |
6 | BIOENGN BIOINFORMAT | 131153 | 6% | 7% | 47 |
7 | CRC IMATGE MOL CRC CIM | 83771 | 0% | 100% | 2 |
8 | MITOCHONDRIAL STRUCT FUNCT | 83771 | 0% | 100% | 2 |
9 | DUNN HUMAN NUTR UNIT | 77648 | 4% | 6% | 31 |
10 | NANOTHER EUT | 75385 | 1% | 30% | 6 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHEMISTRY-MOSCOW | 29177 | 10% | 1% | 71 |
2 | MITOCHONDRION | 8844 | 2% | 1% | 15 |
3 | AGING-US | 6648 | 2% | 1% | 12 |
4 | ANTIOXIDANTS & REDOX SIGNALING | 2644 | 2% | 0% | 14 |
5 | BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2290 | 4% | 0% | 27 |
6 | REDOX BIOLOGY | 2199 | 1% | 1% | 5 |
7 | ADVANCED DRUG DELIVERY REVIEWS | 1878 | 2% | 0% | 11 |
8 | BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS | 1349 | 2% | 0% | 11 |
9 | JOURNAL OF LIPOSOME RESEARCH | 1134 | 1% | 1% | 4 |
10 | MOLECULAR PHARMACEUTICS | 1062 | 1% | 0% | 9 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MITOCHONDRIA TARGETED ANTIOXIDANTS | 1363500 | 6% | 71% | 46 | Search MITOCHONDRIA+TARGETED+ANTIOXIDANTS | Search MITOCHONDRIA+TARGETED+ANTIOXIDANTS |
2 | OXYS RATS | 1140315 | 5% | 83% | 33 | Search OXYS+RATS | Search OXYS+RATS |
3 | SKQ1 | 1046096 | 4% | 78% | 32 | Search SKQ1 | Search SKQ1 |
4 | MITOQ | 806960 | 5% | 57% | 34 | Search MITOQ | Search MITOQ |
5 | MITO PORTER | 589010 | 2% | 94% | 15 | Search MITO+PORTER | Search MITO+PORTER |
6 | TRIPHENYLPHOSPHONIUM | 521944 | 2% | 69% | 18 | Search TRIPHENYLPHOSPHONIUM | Search TRIPHENYLPHOSPHONIUM |
7 | MITOCHONDRIAL DRUG DELIVERY | 471904 | 2% | 87% | 13 | Search MITOCHONDRIAL+DRUG+DELIVERY | Search MITOCHONDRIAL+DRUG+DELIVERY |
8 | MITOCHONDRIAL GENE THERAPY | 463958 | 2% | 92% | 12 | Search MITOCHONDRIAL+GENE+THERAPY | Search MITOCHONDRIAL+GENE+THERAPY |
9 | SKQ | 463958 | 2% | 92% | 12 | Search SKQ | Search SKQ |
10 | DQASOMES | 380773 | 1% | 91% | 10 | Search DQASOMES | Search DQASOMES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | JEAN, SR , TULUMELLO, DV , WISNOVSKY, SP , LEI, EK , PEREIRA, MP , KELLEY, SO , (2014) MOLECULAR VEHICLES FOR MITOCHONDRIA! CHEMICAL BIOLOGY AND DRUG DELIVERY.ACS CHEMICAL BIOLOGY. VOL. 9. ISSUE 2. P. 323-333 | 60 | 56% | 23 |
2 | SMITH, RAJ , HARTLEY, RC , MURPHY, MP , (2011) MITOCHONDRIA-TARGETED SMALL MOLECULE THERAPEUTICS AND PROBES.ANTIOXIDANTS & REDOX SIGNALING. VOL. 15. ISSUE 12. P. 3021 -3038 | 66 | 44% | 87 |
3 | MADAK, JT , NEAMATI, N , (2015) MEMBRANE PERMEABLE LIPOPHILIC CATIONS AS MITOCHONDRIAL DIRECTING GROUPS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 15. ISSUE 8. P. 745 -766 | 69 | 35% | 10 |
4 | APOSTOLOVA, N , VICTOR, VM , (2015) MOLECULAR STRATEGIES FOR TARGETING ANTIOXIDANTS TO MITOCHONDRIA: THERAPEUTIC IMPLICATIONS.ANTIOXIDANTS & REDOX SIGNALING. VOL. 22. ISSUE 8. P. 686 -729 | 89 | 26% | 11 |
5 | ANDERS, MW , (2013) EXPLOITING ENDOBIOTIC METABOLIC PATHWAYS TO TARGET XENOBIOTIC ANTIOXIDANTS TO MITOCHONDRIA.MITOCHONDRION. VOL. 13. ISSUE 5. P. 454-463 | 50 | 52% | 3 |
6 | SMITH, RAJ , MURPHY, MP , (2011) MITOCHONDRIA-TARGETED ANTIOXIDANTS AS THERAPIES.DISCOVERY MEDICINE. VOL. 11. ISSUE 57. P. 106 -114 | 39 | 62% | 35 |
7 | JEAN, SR , AHMED, M , LEI, EK , WISNOVSKY, SP , KELLEY, SO , (2016) PEPTIDE-MEDIATED DELIVERY OF CHEMICAL PROBES AND THERAPEUTICS TO MITOCHONDRIA.ACCOUNTS OF CHEMICAL RESEARCH. VOL. 49. ISSUE 9. P. 1893 -1902 | 28 | 64% | 4 |
8 | PATHAK, RK , KOLISHETTI, N , DHAR, S , (2015) TARGETED NANOPARTICLES IN MITOCHONDRIAL MEDICINE.WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY. VOL. 7. ISSUE 3. P. 315 -329 | 44 | 42% | 11 |
9 | GRUBER, J , FONG, S , CHEN, CB , YOONG, S , PASTORIN, G , SCHAFFER, S , CHEAH, I , HALLIWELL, B , (2013) MITOCHONDRIA-TARGETED ANTIOXIDANTS AND METABOLIC MODULATORS AS PHARMACOLOGICAL INTERVENTIONS TO SLOW AGEING.BIOTECHNOLOGY ADVANCES. VOL. 31. ISSUE 5. P. 563 -592 | 77 | 25% | 28 |
10 | LUKASHEV, AN , SKULACHEV, MV , OSTAPENKO, V , SAVCHENKO, AY , PAVSHINTSEV, VV , SKULACHEV, VP , (2014) ADVANCES IN DEVELOPMENT OF RECHARGEABLE MITOCHONDRIA! ANTIOXIDANTS.MITOCHONDRION IN AGING AND DISEASE. VOL. 127. ISSUE . P. 251 -265 | 30 | 67% | 2 |
Classes with closest relation at Level 1 |